| Reviews |
 |
|
|
|
|
Reviews to:
Date: Sunday, 15. November 2015
Author: Gast
Review:
I\'d like to apply for this job prolatis recall Celgene Corp, up 7 percent to $133.86, was amongthe top performers for both the S&P 500 and the Nasdaq 100 after the company said a late-stage trial of its cancerdrug Revlimid met the main goal of improving survival in newlydiagnosed blood cancer patients.
Evaluation:  |
|
|
|
| Shopping Cart |
 |
|
| You do not have any products in your shopping cart yet. |
|
|
Customer group:Guest
|
|
|
|
